SEARCH

SEARCH BY CITATION

References

  • Bader, P., Schilling, F., Schlaud, M., Girgert, R., Handgretinger, R., Klingebiel, T., Treuner, J., Liu, C., Niethammer, D. & Beck, J.F. (1999) Expression analysis of multidrug resistance associated genes in neuroblastomas. Oncological Reports, 6, 11431146.
  • Beck, J., Handgretinger, R., Dopfer, R., Klingebiel, T., Niethammer, D. & Gekeler, V. (1995) Expression of mdr1, mrp, topoisomerase II alpha/beta, and cyclin A in primary or relapsed states of acute lymphoblastic leukaemias. British Journal of Haematology, 89, 356363.
  • Beck, J., Handgretinger, R., Klingebiel, T., Dopfer, R., Schaich, M., Ehninger, G., Niethammer, D. & Gekeler, V. (1996) Expression of PKC isozyme and MDR-associated genes in primary and relapsed state AML. Leukemia, 10, 426433.
  • Bradshaw, D.M. & Arceci, R.J. (1998) Clinical relevance of transmembrane drug efflux as a mechanism of multidrug resistance. Journal of Clinical Oncology, 16, 36743690.
  • Butturini, A., Santucci, M.A., Gale, R.P., Perocco, P. & Tura, S. (1990) GM-CSF incubation prior to treatment with cytarabine or doxorubicin enhances drug activity against AML cells in vitro: a model for leukemia chemotherapy. Leukemia Research, 14, 743749.
  • Chin, K.V., Ueda, K., Pastan, I. & Gottesman, M.M. (1992) Modulation of activity of the promoter of the human MDR1 gene by Ras and p53. Science, 255, 459462.
  • Coghlan, D.W., Morley, A.A., Matthews, J.P. & Bishop, J.F. (1994) The incidence and prognostic significance of mutations in codon 13 of the N-ras gene in acute myeloid leukemia. Leukemia, 8, 16821687.
  • Darley, R.L. & Burnett, A.K. (1999) Mutant RAS inhibits neutrophil but not macrophage differentiation and allows continued growth of neutrophil precursors. Experimental Hematology, 27, 15991608.DOI: 10.1016/s0301-472x(99)00100-9
  • De Melo, M.B., Lorand-Metze, I., Lima, C.S., Saad, S.T. & Costa, F.F. (1997) N-ras gene point mutations in Brazilian acute myelogenous leukemia patients correlate with a poor prognosis. Leukemia and Lymphoma, 24, 309317.
  • Demetri, G.D., Ernst, T.J., Pratt, E.S., Zenzie, B.W., Rheinwald, J.G. & Griffin, J.D. (1990) Expression of ras oncogenes in cultured human cells alters the transcriptional and posttranscriptional regulation of cytokine genes. Journal of Clinical Investigations, 86, 12611269.
  • Denhardt, D.T. (1996) Signal-transducing protein phosphorylation cascades mediated by Ras/Rho proteins in the mammalian cell: the potential for multiplex signalling. Biochemical Journal, 318, 729747.
  • Endicott, J.A. & Ling, V. (1989) The biochemistry of P-glycoprotein-mediated multidrug resistance. Annual Review of Biochemistry, 58, 137171.
  • Gramatzki, M., Ludwig, W.D., Burger, R., Moos, P., Rohwer, P., Grunert, C., Sendler, A., Kalden, J.R., Andreesen, R., Henschke, F. & Moldenhauer, G. (1998) Antibodies TC-12 (‘unique’) and TH-111 (CD96) characterize T-cell acute lymphoblastic leukemia and a subgroup of acute myeloid leukemia. Experimental Hematology, 26, 12091214.
  • Grant, C.E., Valdimarsson, G., Hipfner, D.R., Almquist, K.C., Cole, S.P. & Deeley, R.G. (1994) Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Research, 54, 357361.
  • Illmer, T., Schaich, M., Oelschlagel, U., Nowak, R., Renner, U., Ziegs, B., Subat, S., Neubauer, A. & Ehninger, G. (1999) A new PCR MIMIC strategy to quantify low mdr1 mRNA levels in drug resistant cell lines and AML blast samples. Leukemia Research, 23, 653663.DOI: 10.1016/s0145-2126(99)00076-4
  • Izquierdo, M.A., Shoemaker, R.H., Flens, M.J., Scheffer, G.L., Wu, L., Prather, T.R. & Scheper, R.J. (1996) Overlapping phenotypes of multidrug resistance among panels of human cancer-cell lines. International Journal of Cancer, 65, 230237.DOI: 10.1002/(sici)1097-0215(19960117)65:2<230::aid-ijc17>3.3.co;2-e
  • Kiyoi, H., Naoe, T., Nakano, Y., Yokota, S., Minami, S., Miyawaki, S., Asou, N., Kuriyama, K., Jinnai, I., Shimazaki, C., Akiyama, H., Saito, K., Oh, H., Motoji, T., Omoto, E., Saito, H., Ohno, R. & Ueda, R. (1999) Prognostic implication of FLT3 and N-RAS gene mutations in acute myeloid leukemia. Blood, 93, 30743080.
  • Koo, H.M., Gray-Goodrich, M., Kohlhagen, G., McWilliams, M.J., Jeffers, M., Vaigro-Wolff, A., Alvord, W.G., Monks, A., Paull, K.D., Pommier, Y. & Vande, W.G. (1999) The ras oncogene-mediated sensitization of human cells to topoisomerase II inhibitor-induced apoptosis. Journal of the National Cancer Institute, 91, 236244.DOI: 10.1093/jnci/91.3.236
  • Leith, C.P., Kopecky, K.J., Chen, I.M., Eijdems, L., Slovak, M.L., McConnell, T.S., Head, D.R., Weick, J., Grever, M.R., Appelbaum, F.R. & Willman, C.L. (1999) Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: a Southwest Oncology Group Study. Blood, 94, 10861099.
  • List, A.F., Spier, C.S., Grogan, T.M., Johnson, C., Roe, D.J., Greer, J.P., Wolff, S.N., Broxterman, H.J., Scheffer, G.L., Scheper, R.J. & Dalton, W.S. (1996) Overexpression of the major vault transporter protein lung-resistance protein predicts treatment outcome in acute myeloid leukemia. Blood, 87, 24642469.
  • Lowy, D.R. & Willumsen, B.M. (1993) Function and regulation of ras. Annual Review of Biochemistry, 62, 851891.
  • Matsuda, S., Gotoh, Y. & Nishida, E. (1994) Signaling pathways mediated by the mitogen-activated protein (MAP) kinase kinase/MAP kinase cascade. Journal of Leukocyte Biology, 56, 548553.
  • Neubauer, A., Dodge, R.K., George, S.L., Davey, F.R., Silver, R.T., Schiffer, C.A., Mayer, R.J., Ball, E.D., Wurster-Hill, D. & Bloomfield, C.D. (1994) Prognostic importance of mutations in the ras proto-oncogenes in de novo acute myeloid leukemia. Blood, 83, 16031611.
  • Prendergast, G.C. & Gibbs, J.B. (1993) Pathways of Ras function: connections to the actin cytoskeleton. Advances in Cancer Research, 62, 1964.
  • Radich, J.P., Kopecky, K.J., Willman, C.L., Weick, J., Head, D., Appelbaum, F. & Collins, S.J. (1990) N-ras mutations in adult de novo acute myelogenous leukemia: prevalence and clinical significance. Blood, 76, 801807.
  • Ramachandran, C., Mead, D., Wellham, L.L., Sauerteig, A. & Krishan, A. (1995) Expression of drug resistance-associated mdr-1, GST pi, and topoisomerase II genes during cell cycle traverse. Biochemistry and Pharmacology, 49, 545552.
  • Raza, A., Maheshwari, Y. & Preisler, H.D. (1987) Differences in cell cycle characteristics among patients with acute nonlymphocytic leukemia. Blood, 69, 16471653.
  • Schaich, M., Neu, S., Beck, J., Gekeler, V., Schuler, U. & Ehninger, G. (1997) A novel method for direct and fluorescence independent determination of drug efflux out of leukemic blast cells. Leukemia Research, 21, 933940.DOI: 10.1016/s0145-2126(97)00052-0
  • Scheffer, G.L., Wijngaard, P.L., Flens, M.J., Izquierdo, M.A., Slovak, M.L., Pinedo, H.M., Meijer, C.J., Clevers, H.C. & Scheper, R.J. (1995) The drug resistance-related protein LRP is the human major vault protein. Nature Medicine, 1, 578582.
  • Schmidt, M., Nagel, S., Proba, J., Thiede, C., Ritter, M., Waring, J.F., Rosenbauer, F., Huhn, D., Wittig, B., Horak, I. & Neubauer, A. (1998) Lack of interferon consensus sequence binding protein (ICSBP) transcripts in human myeloid leukemias. Blood, 91, 2229.
  • Schuurhuis, G.J., De Broxterman, H.J., Lange, J.H., Pinedo, H.M., Van Heijningen, T.H., Kuiper, C.M., Scheffer, G.L., Scheper, R.J., Van Kalken, C.K. & Baak, J.P. (1991) Early multidrug resistance, defined by changes in intracellular doxorubicin distribution, independent of P-glycoprotein. British Journal of Cancer, 64, 857861.
  • Shannon, K. (1995) The Ras signaling pathway and the molecular basis of myeloid leukemogenesis. Current Opinions in Hematology, 2, 305308.
  • Smeets, M.E., Raymakers, R.A., Vierwinden, G., Pennings, A.H., Wessels, H. & De Witte, T. (1999) Triggering noncycling hematopoietic progenitors and leukemic blasts to proliferate increases anthracycline retention and toxicity by downregulating multidrug resistance. Blood, 94, 24142423.
  • Tarasiuk, J., Foucrier, J. & Garnier-Suillerot, A. (1993) Cell cycle dependent uptake and release of anthracycline by drug-resistant and drug-sensitive human leukaemic K562 cells. Biochemistry and Pharmacology, 45, 18011808.
  • Thiede, C., Bayerdorffer, E., Blasczyk, R., Wittig, B. & Neubauer, A. (1996) Simple and sensitive detection of mutations in the ras proto-oncogenes using PNA-mediated PCR clamping. Nucleic Acids Research, 24, 983984.DOI: 10.1093/nar/24.5.983
  • Volm, M., Mattern, J. & Koomagi, R. (1997) Expression of lung resistance-related protein (LRP) in non-small cell lung carcinomas of smokers and non-smokers and its predictive value for doxorubicin resistance. Anticancer Drugs, 8, 931936.